Jeffrey M. Dayno - Jul 22, 2021 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
Chief Medical Officer
Signature
/s/ Christian Ulrich, Attorney-in-fact
Stock symbol
HRMY
Transactions as of
Jul 22, 2021
Transactions value $
-$1,089
Form type
4
Date filed
7/23/2021, 04:30 PM
Next filing
Aug 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRMY Common Stock Options Exercise $411 +50 $8.22* 50 Jul 22, 2021 Direct
transaction HRMY Common Stock Sale -$1.5K -50 -100% $30.00 0 Jul 22, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Options Exercise $0 -50 -0.05% $0.00 103K Jul 22, 2021 Common Stock 50 $8.22 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The stock option is currently vested with respect to 82,777 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 13, 2021.